Kopin to Showcase Portfolio of Spatial Light Modulators and Microdisplays at Laser World of Photonics 2025
WESTBOROUGH, Mass.--(BUSINESS WIRE)--Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced will be presenting its range of cutting-edge spatial light modulators (SLMs) and microdisplays at this year's Laser World of Photonics, taking place from June 24–27 at the Munich Trade Fair Center. Attendees can explore the latest advancements at Hall B2, Booth 137.
A highlight of Kopin's exhibit is its high-resolution binary phase modulator, featuring a pixel array of 2048 x 2048. Engineered for exceptionally fast refresh rates and stable diffraction, this SLM is uniquely suited for advanced applications such as 3D metrology and Super Resolution Microscopy.
Kopin's SLMs are seamlessly integrated with its range of LCD and OLED microdisplays, optimized for Near-Eye applications. These displays are designed for precision and performance and can be custom-tailored for integration into application-specific optical systems.
Taking center stage at the booth is a medical Head-Mounted Display (HMD), purpose built for surgeons, offering an ergonomic, high-resolution viewing experience for both 2D and 3D surgical applications.
'We look forward to demonstrating how Kopin's display solutions empower optical system designers, scientists, and surgeons with uncompromised performance,' said Bill Maffucci, SVP Business Development and Strategy, Kopin Corporation. 'Laser World of Photonics provides the perfect stage to connect with global innovators and share our latest breakthroughs.'
To schedule a meeting during the show, contact sales@kopin.com.
About Kopin
Kopin Corporation is a leading developer and provider of innovative display, and application-specific optical solutions sold as critical components and subassemblies for defense, enterprise, professional and consumer products. Kopin's portfolio includes microdisplays, display modules, eyepiece assemblies, image projection modules, and vehicle mounted and head-mounted display systems that incorporate ultra-small high-resolution Active Matrix Liquid Crystal displays (AMLCD), Ferroelectric Liquid Crystal on Silicon (FLCoS) displays, MicroLED displays (µLED) and Organic Light Emitting Diode (OLED) displays, a variety of optics, and low-power ASICs. For more information, please visit Kopin's website at www.kopin.com. Kopin is a trademark of Kopin Corporation.
Forward-Looking Statements
Statements in this press release may be considered 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended (the 'Securities Act'), and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'), which are subject to the safe harbor created by such sections. Words such as 'expects,' 'believes,' 'can,' 'will,' 'estimates,' and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. We caution readers not to place undue reliance on any such 'forward-looking statements,' which speak only as of the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. Various factors, some of which are beyond our control, could cause actual results to differ materially from those expressed in, or implied by, such forward-looking statements. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as may otherwise be required by the federal securities laws. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management's expectations are described in Part I, Item 1A. Risk Factors; Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form 10-K for the fiscal year ended December 28, 2024, as amended, or as updated from time to time by our Securities and Exchange Commission filings.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
26 minutes ago
- Business Insider
Nvidia Stock Lands a New Street-High Price Target
Nvidia (NASDAQ:NVDA) has built its all-conquering march to the top of the market cap ranks on an unmatched position in the AI chip world. Having secured its dominance in this segment, another major wave of growth could now be on the horizon. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. In fact, Loop Capital analyst Ananda Baruah believes that momentum is already building, pointing to fieldwork that signals we are 'entering the next 'Golden Wave' of Gen AI adoption,' with the Jensen Huang-led company set to reap the rewards once again. 'NVDA is at the front-end of another material leg of stronger than anticipated demand (much like we saw in 2023 into 2024),' the analyst went on to say. In short, the analyst argues that Hyperscale is far bigger than most people realize. Baruah's analysis suggests Hyperscalers are on track to significantly ramp up their use of non-CPU compute – like GPUs, custom silicon, and AI accelerators – from around 15% today to between 50% and 60% of total compute by 2028, which could represent close to $900 billion on its own. At the same time, Nvidia's AI Factory initiative, which targets non-Hyperscaler customers, appears to have a clear path to tens of gigawatts of demand over the next two to three years, equating to a potential $450 to $900 billion opportunity, by Baruah's estimates. 'NVDA is sitting right in the middle of quickly converging dynamics which they both have worked to empower and are now material beneficiaries of,' the analyst further explained. Meanwhile, Blackwell has officially arrived. After some initial yield challenges with the B200 leading into the March quarter, followed by a temporary slowdown in the June quarter as customers held off for the B300 (with deliveries set to begin in July), Nvidia is now on track to reach full-scale production by the October quarter. Baruah's 'bottom-up checks' also support his broader outlook, with GPU shipments in 2025 and 2026 expected to hit around 6.5 million and 7.5 million units respectively (excluding China), with average selling prices near $40,000. Driving these numbers higher, Baruah points out, is the surge in reasoning models, which are far more compute- and token-intensive than initially realized and were not even accounted for in most forecasts before November 2024. Nvidia's GB200/300 NVL72 architecture is well-positioned to serve these demanding workloads, for both training and inference. Adding yet another dimension to Nvidia's positioning is the rise of Neoclouds, which Baruah describes as having become Nvidia's 'de-facto Data Center Arm.' Over the past nine months, Nvidia has strategically shifted its posture to treat these partners almost as extensions of its own infrastructure, strengthening the company's long-term ecosystem advantage. With all these growth catalysts aligning, Baruah believes a higher price target is justified — and he is setting a Street-high forecast at $250, suggesting Nvidia shares could rally 58% over the next year. It hardly needs adding but Baruah's rating stays a Buy. (To watch Baruah's track record, click here) It's mostly Buys elsewhere on the Street too; 34 other analysts join the bull camp and with an additional 4 Holds and 1 Sell, the consensus view is that this stock is a Strong Buy. At $175.28, the average price target factors in a one-year gain of 11%. (See NVDA stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Business Wire
an hour ago
- Business Wire
From Waste to Strategic Metals: Circular Materials Achieves First Industrial-Scale Recoveries Under the Critical Raw Materials Act
PADUA, Italy--(BUSINESS WIRE)--Circular Materials announces two major milestones under the Critical Raw Materials Act: the recovery from industrial wastewater of the first kilogram of ruthenium and the first ton of nickel, preventing the release of heavy metals into the environment. These results were secured through strong collaborations with two leading companies in surface treatments: LEM, core company of the LEM INDUSTRIES Group, specialized in the luxury sector, and Argos Surface Technologies Group, a leader in industrial coatings. We recover what the world needs most: Circular Materials delivers first industrial-scale metal recoveries. This success comes just a few months after the European Commission recognized Recover-IT as a strategic project, confirming the pivotal role of Circular Materials in securing critical raw material supplies, increasing recycling, and reducing the EU's dependence on imports. Ruthenium and Nickel: crucial metals for a sustainable future Ruthenium, a noble metal from the platinum group, is essential for cutting-edge sectors such as advanced electronics, green hydrogen production, fine chemicals, fuel cells, and luxury goods. Nickel, on the other hand, is a critical element, essential in advanced steels and lithium batteries —pillars of the energy transition. Circular Materials' proprietary SWaP (Supercritical Water Precipitation) technology delivers exceptional effectiveness and versatility to recover precious and industrially intensive metals. A revolutionary environmental impact: carbon negative and beyond Life Cycle Assessment (LCA) of the process applied to ruthenium and nickel reveals a remarkable environmental benefit. For ruthenium, emissions are reduced by over 99.6% compared to traditional mining. Even more impressive is the result for nickel: the SWaP process not only reduces emissions but becomes carbon negative, actively avoiding the total CO₂ production associated with conventional methods. ' Circular Materials strengthens its technological leadership and, together with its partners, builds a solid and integrated circular supply chain capable of transforming industrial waste into new resources, preventing the loss of critical materials,' says Marco Bersani, Founder & CEO of Circular Materials. ' With the industrial-scale recovery of ruthenium and nickel, we are shaping a strategy that reduces dependence on external sources, lowers the environmental impact of production processes, and valorizes waste streams that until now have been dispersed '. In a global context marked by the impacting scarcity of critical resources and the need to ensure a secure and sustainable supply, Circular Materials stands out as a key player in a new European industrial paradigm focused on recovering the resources the world needs most. About Us: Circular Materials Circular Materials is a groundbreaking company with proprietary technology for the recovery of strategic metals from industrial wastewater through a sustainable and highly efficient process. The company has developed and patented the Supercritical Water Precipitation (SWaP) technology, which simultaneously treats wastewater and recovers metal, eliminating toxic sludge production and significantly reducing environmental impact, both in terms of waste and emissions.
Business Wire
an hour ago
- Business Wire
Syngenta to Become Global Leader in Biologicals; Expanding Nature Inspired Solutions for Farmers
BASEL, Switzerland--(BUSINESS WIRE)--Syngenta is accelerating the rollout of its nature-inspired, science-based biological solutions, responding to rising demand for sustainable, high-performance tools that help farmers boost productivity efficiently and responsibly. It also contributes toward Syngenta's fulfilment of commitments outlined in its Sustainability Priorities. Jonathan Brown, Global Head Biologicals & Seedcare, comments: 'With our recent partnerships and acquisitions and extended manufacturing capacities, Syngenta is positioning itself as the leader in biologicals. Our scientific expertise is at the forefront of our research and development efforts to provide farmers with the next generation of biologicals, helping them transition towards more sustainable farming practices, such as regenerative agriculture.' In December 2024, the company acquired Intrinsyx Bio, a California-based start-up specializing in the development of nutrient-use efficiency products. Most recently, in early 2025, Syngenta concluded the integration of Novartis' Strains and Natural Products Collection, the repository of natural compounds and genetic strains for agricultural use. These additions will accelerate the development of biologicals, bringing new tools to the market as a sustainable complement to conventional crop protection solutions. Also in 2025, Syngenta opened a 22,000 m² biologicals facility in Orangeburg, South Carolina, in the United States, which is purpose-built to produce 16,000 tons of biostimulants annually. This new manufacturing facility complements Syngenta's existing global network of biologicals' manufacturing facilities in Brazil, Italy, India and Norway. These strategic milestones effectively enhance both Syngenta's R&D, operating out of the centers of excellence in Stein, Switzerland; Jealott's Hill, UK; Atessa, Italy; and production capacity for biologicals, facilitating Syngenta's roll out of its biologicals pipeline, with multiple candidates demonstrating strong commercial potential with projected annual sales above USD 100 million. Syngenta Biologicals posted strong Q1 2025 results, with standout performance in North America and China. The global biologicals market is growing at around 10% CAGR and is projected to reach nearly USD 20 billion by 2030, according to AgbioInvestor and Syngenta's estimate, underlining the pivotal role of biologicals in the future of sustainable farming. Derived predominantly from naturally occurring substances, biologicals offer significant potential for sustainable agriculture. The market can be categorized into three main categories: Biocontrols – Naturally derived products for managing pests, diseases, and weeds. Biostimulants – Products enhancing natural plant processes to improve abiotic stress tolerance and crop quality. Nutrient Use Efficiency (NUE) products – Any substance or microorganism to improve macro- and micronutrient availability and uptake to promote growth and enhance yield. About Syngenta Syngenta is a global leader in agricultural innovation with a presence in more than 90 countries. Syngenta is focused on developing technologies and farming practices that empower farmers, so they can make the transformation required to feed the world's population while preserving our planet. Its bold scientific discoveries deliver better benefits for farmers and society on a bigger scale than ever before. Guided by its Sustainability Priorities, Syngenta is developing new technologies and solutions that support farmers to grow healthier plants in healthier soil with a higher yield. Syngenta Crop Protection is headquartered in Basel, Switzerland; Syngenta Seeds is headquartered in the United States. Read our stories and follow us on LinkedIn, Instagram & X. Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR ('legitimate interest'). However, if you do not wish to receive further information about Syngenta, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our privacy statement. Cautionary Statement Regarding Forward-Looking Statements This document may contain forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Syngenta, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions, or other factors. ©2025 Syngenta. Rosentalstrasse 67, 4058 Basel, Switzerland.
